| Q39184022 | A sensitive photometric assay for monoamine oxidase |
| Q66929439 | Activation of platelet monoamine oxidase by plasma in the human |
| Q67443285 | Anti-depressant potentiation of 5-hydroxytryptophan by L-deprenyl, an MAO "type B" inhibitor |
| Q71169359 | Assay for monoamine oxidases A and B by high-performance liquid chromatography with fluorescence detection |
| Q55062255 | Barrier mechanisms for neurotransmitter monoamines and their precursors at the blood-brain interface |
| Q39667185 | Brain region differences and some characteristics of monoamine oxidase type a and b activities in the vervet monkey |
| Q39673742 | Comparative behavioral effects of clorgyline and pargyline in man: A preliminary evaluation |
| Q51863023 | Deamination of released 3H-noradrenaline in the canine saphenous vein. |
| Q93660905 | Determination of phenylethanolamine N-methyltransferase by high-performance liquid chromatography with fluorescence detection |
| Q52301818 | Developmental aspects of rat heart monoamine oxidase |
| Q70753411 | Dexamethasone selectively increases monoamine oxidase type a in human skin fibroblasts |
| Q67006695 | Differences in A and B forms of monoamine oxidase revealed by limited proteolysis and peptide mapping |
| Q42471611 | Early changes in mitochondrial monoamine oxidase activity of rat liver during 2-acetylaminofluorene feeding |
| Q71491251 | Effect of riboflavin on monoamine oxidase activity in cultured neuroblastoma cells |
| Q48214905 | Effects of L-DOPA administration upon monoamine oxidase activity in rat tissues |
| Q51831352 | Effects of clorgyline and (-)deprenyl on the deamination of normetanephrine and noradrenaline in strips and homogenates of the canine saphenous vein. |
| Q48911414 | Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum |
| Q44217628 | Effects of tryptamine mediated through 2 states of the 5-HT2 receptor in calf coronary artery |
| Q41829844 | Electrophysiological effects of monoamine oxidase inhibition on rat midbrain dopaminergic neurones: an in vitro study. |
| Q48560321 | Ethanol inhibits the activity of the B form of monoamine oxidase in human platelet and brain tissue |
| Q40021206 | Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine |
| Q55488243 | Expression of A and B types of monoamine oxidase in differentiated neuroblastoma hybrid cells. |
| Q41497798 | Histochemical characterization of monoamine oxidase in ependyma of rat hypothalamus |
| Q48627274 | Histochemical localization of monoamine oxidase in whole-body, freeze-dried sections of mice |
| Q48882193 | Immunological studies of human monoamine oxidases |
| Q39423856 | Implications of combined treatment with 'Madopar' and L-deprenil in Parkinson's disease. A long-term study |
| Q72616330 | Indoleamine Metabolism in Rat Brain Studied Through Measurements of Tryptophan, 5-Hydroxyindoleacetic Acid, and Indoleacetic Acid in Cerebrospinal Fluid |
| Q43917982 | Influence of food on the tyramine pressor effect during chronic moclobemide treatment of healthy volunteers |
| Q67013697 | Inhibition of both MAO-A and MAO-B required for the production of hypermotility in mice with the 5HT uptake inhibitors chlorimipramine and femoxetine |
| Q34397267 | Inhibition of monoamine oxidase by moclobemide: effects on monoamine metabolism and secretion of anterior pituitary hormones and cortisol in healthy volunteers |
| Q48247985 | Inhibition of monoamine oxidase-A of rat brain by pyrethroids--an in vitro kinetic study |
| Q52068209 | Interactions of tricyclic antidepressant drugs with human and rat monoamine oxidase type B. |
| Q71151441 | Localization of monoamine oxidase of type A and B in blood vessels with different innervation patterns |
| Q48935047 | Localization of monoamine oxidases A and B in primate brains relative to neuron-specific and non-neuronal enolases |
| Q71003538 | MAO-A and MAO-B in the superior cervical ganglion and in the nictitating membrane of the cat |
| Q48712942 | Metabolism of the monoamine oxidase-B inhibitor, MD 780236 and its enantiomers by the A and B forms of the enzyme in the rat |
| Q49012425 | Monoamine oxidase (MAO) activity as a determinant in human neurophysiology |
| Q40160379 | Monoamine oxidase A and B in cultured cells |
| Q67247908 | Monoamine oxidase A and B: A useful concept? |
| Q72497792 | Monoamine oxidase in frog liver and brain |
| Q70460174 | Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium |
| Q48201670 | Monoamine oxidase in rat and bovine endocrine tissues |
| Q48757927 | Monoamine oxidase inhibition causes a long-term prolongation of the dopamine-induced responses in rat midbrain dopaminergic cells. |
| Q39185795 | Monoamine oxidase inhibitory properties of 5-hydroxymethyl-3-m-tolyloxazolidin-2-one (toloxatone) |
| Q70435103 | Monoamine oxidase of types A and B in the saphenous vein and mesenteric artery of the dog |
| Q41504671 | Nonexistence of a type C monoamine oxidase in rat brain |
| Q67443278 | On the mode of action of L-deprenyl in the human central nervous system |
| Q36941119 | Platelet monoamine oxidase B activity in parkinsonian patients |
| Q71390899 | Properties of monoamine oxidase in control and Lesch-Nyhan fibroblasts |
| Q50915786 | Quantitative aspects of the histochemical tetrazolium salt reaction on monoamine oxidase activity in rat liver. |
| Q48562584 | Radioactive N,N-dimethylphenylethylamine: a selective radiotracer for in vivo measurement of monoamine oxidase-B activity in the brain |
| Q39673747 | Selectivity of clorgyline and pargyline as inhibitors of monoamine oxidases A and B in vivo in man |
| Q44658904 | Some cardiovascular effects of monoamine oxidase inhibitors in unanaesthetized rats |
| Q39267749 | Substrate and inhibitor selectivity of human heart monoamine oxidase |
| Q39776255 | Substrate-selective monoamine oxidases—inhibitor, tissue, species and functional differences |
| Q28331143 | Substrate-typic changes of platelet monoamine oxidase activity in sub-types of schizophrenia |
| Q67650337 | Synthesis, Biological Evaluation and Quantitative Structure Activity Relationship Analysis of Nuclear-substituted Pargylines as Competitive Inhibitors of MAO-A and MAO-B |
| Q67443276 | The active centers of monoamine oxidase types "A" and "B": binding with (14C)-clorgyline and (14C)-deprenyl |
| Q70804953 | The effect of tryptolines (1, 2, 3, 4-tetrahydro-β-carbolines) on monoamine metabolism and the platelet aggregation response in human platelets |
| Q49126966 | The effects of chronic manganese feeding on the activity of monoamine oxidase in various organs of the developing rat |
| Q39209029 | The effects of homogenization of rat liver in different buffer solutions on the yield and kinetic properties of monoamine oxidase |
| Q48878160 | The functional significance of the pentose phosphate pathway in synaptosomes: protection against peroxidative damage by catecholamines and oxidants |
| Q39196946 | The inhibition by clorgyline of 5-hydroxytryptamine deamination by the rat liver |
| Q28327968 | The metabolism of 3-amino-1-chloropropan-2-ol in relation to its antifertility activity in male rats |
| Q39232317 | The metabolism of 5-hydroxytryptamine and beta-phenylethylamine in perfused rat lung and in vitro |
| Q39217629 | Twenty-four-hour variation of 5-hydroxytryptophan decarboxylase and monoamine oxidase activities in the eyestalks of the fiddler crab, UCA pugilator |
| Q36128618 | Tyramine antagonistic properties of AGN 1135, an irreversible inhibitor of monoamine oxidase type B. |
| Q71564913 | Tyramine infusions and selective monoamine oxidase inhibitor treatment. I. Changes in pressor sensitivity |
| Q69962076 | Tyramine pressor sensitivity changes during deprenyl treatment |
| Q28293084 | Tyramine pressor sensitivity in healthy subjects during combined treatment with moclobemide and selegiline |